Evidence map›Paper›PMID 41143210›Full record

ArticleNature machine intelligence2025

Tailored structured peptide design with a key-cutting machine approach.

Yan C Leyva, Marcelo D T Torres, Carlos A Oliva, Cesar de la Fuente-Nunez, Carlos A Brizuela

Abstract read
In one paragraph

Article in Nature machine intelligence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yan C Leyva *Computer Science Department, Center for Scientific Research and Higher Education at Ensenada (CICESE), Ensenada, Mexico.
Marcelo D T Torres *Machine Biology Group, Departments of Psychiatry and Microbiology, Institute for Biomedical Informatics, Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA USA.ORCID 0000-0002-6165-9138
Carlos A OlivaComputer Science Department, Center for Scientific Research and Higher Education at Ensenada (CICESE), Ensenada, Mexico.
Cesar de la Fuente-NunezMachine Biology Group, Departments of Psychiatry and Microbiology, Institute for Biomedical Informatics, Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA USA.ORCID 0000-0002-2005-5629
Carlos A BrizuelaComputer Science Department, Center for Scientific Research and Higher Education at Ensenada (CICESE), Ensenada, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Computational protein and peptide design is emerging as a transformative framework for engineering macromolecules with precise structures and functions, offering innovative solutions in medicine, biotechnology and materials science. However, current methods predominantly rely on generative models, which are expensive to train and modify. Here, we introduce the Key-Cutting Machine (KCM), an optimization-based platform that iteratively leverages structure prediction to match desired backbone geometries. KCM requires only a single graphics processing unit and enables seamless incorporation of user-defined requirements into the objective function, circumventing the high retraining costs typical of generative models while allowing straightforward assessment of measurable properties. By employing an estimation of distribution algorithm, KCM optimizes sequences on the basis of geometric, physicochemical and energetic criteria. We benchmarked its performance on α-helices, β-sheets, a combination of both and unstructured regions, demonstrating precise backbone geometry design. As a proof of concept, we applied KCM to antimicrobial peptide design by using a template antimicrobial peptide as the 'key', yielding a candidate with potent in vitro activity against multiple bacterial strains and efficacy in a murine infection model. KCM thus emerges as a robust tool for de novo protein and peptide design, offering a flexible paradigm for replicating and extending the structure-function relationships of existing templates.

Indexed as

AntimicrobialsComputational models

Identifiers

PMID41143210
PMCPMC12552119

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.